Effect of 16 Weeks of Bosentan-Based Therapy on Cardiac MRI (cMRI) Derived Ventricular Function, 6-Minute Walk Test Distance (6MWD) and Borg Dyspnea Index (BDI) in Patients with Pulmonary Arterial Hypertension (PAH): Results from the COMPASS-3 Study

被引:0
|
作者
Murali, S. [1 ]
Lloyd, S. G. [2 ]
Gupta, H. [2 ]
Soto, F. J. [3 ]
Park, M. H. [4 ]
Torres, F. [5 ]
Frey, N. [6 ]
Benza, R. L. [1 ]
机构
[1] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Prevea Hlth, Sheboygan, WI USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] Univ Texas SW Med Ctr Dallas, Dallas, TX USA
[6] Actelion Pharmaceut US Inc, San Francisco, CA USA
来源
关键词
D O I
10.1016/j.healun.2009.11.298
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
286
引用
收藏
页码:S97 / S97
页数:1
相关论文
共 3 条
  • [1] Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
    Delcroix, Marion
    Channick, Richard
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Simonneau, Gerald
    Rubin, Lewis
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study
    Benza, Raymond L.
    Raina, Amresh
    Gupta, Himanshu
    Murali, Srinivas
    Burden, Annie
    Zastrow, Michael S.
    Park, Myung H.
    Simon, Marc A.
    [J]. PULMONARY CIRCULATION, 2018, 8 (01)
  • [3] Correlation of Right Heart Catheterization (RHC) Parameters and Functional Tests after 16 Weeks of Bosentan-Based Therapy in Patients with Pulmonary Arterial Hypertension (PAH): The COMPASS-3 Study
    Torres, F.
    Murali, S.
    Soto, F. J.
    Gupta, H.
    Park, M. H.
    Frey, N.
    Benza, R. L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S26 - S26